Snowball logo
logo
HTD

Corcept Therapeutics Inc

€76.72€0.00  (0%)
Estimate
P/E
196.7
EPS
0.39
Beta
0.176
Growth
Revenue, YoY
35.27%
Net income, YoY
25.57%
FCF, YoY
-28.02%
About the company
Ticker
HTD
ISIN
US2183521028
Country
Other
Sector (GICS)
Other

Frequently asked questions

What sector does Corcept Therapeutics Inc (HTD) operate in?

Corcept Therapeutics Inc belongs to the Other sector.

What is Corcept Therapeutics Inc (HTD) current stock price?

As of the latest data, Corcept Therapeutics Inc stock price is €76.72, with a previous close of €76.72.

What is Corcept Therapeutics Inc (HTD) Earnings Per Share (EPS)?

The trailing EPS is €0.39.

What is Corcept Therapeutics Inc (HTD) Price-to-Earnings (P/E) ratio?

Corcept Therapeutics Inc current P/E ratio is 196.72.

What is Corcept Therapeutics Inc (HTD) EBITDA?

Corcept Therapeutics Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 36.91 million.

Does Corcept Therapeutics Inc (HTD) pay dividends?

No. Corcept Therapeutics Inc does not pay a dividend.

When is Corcept Therapeutics Inc (HTD) next earnings report?

Corcept Therapeutics Inc is expected to release its next earnings report on September 30, 2026.

What is Corcept Therapeutics Inc (HTD) beta (volatility) score?

Corcept Therapeutics Inc has a beta of 0.176, indicating lower volatility than the overall market.